Sujatha Rashid
- American Type Culture Collection (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #125
- Top 1% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79558827Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$19.1M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#125
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Sujatha Rashid as a PI. Multi-PI records show the full award amount for context.
- 75N93024C00001-P00001-9999-2N01Contact PIMicrobiology and Infectious Diseases Biological Research Repository (MID-BRR)$15Maward amount
- 75N93024C00001-P00001-9999-1N01Contact PIMicrobiology and Infectious Diseases Biological Research Repository (MID-BRR): AMR Research Activities$3.8Maward amount
- 75N93024C00001-P00001-9999-3N01Contact PIMicrobiology and Infectious Diseases Biological Research Repository (MID-BRR): Universal Influenza Vaccine Research Activities$325Kaward amount
Award organization
Organizations that administered FY2024 awards listing Sujatha Rashid as a PI.
FY2024 award administered by American Type Culture Collection (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardAmerican Type Culture Collection
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024$10M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #125
- 2024Entered Top 25% NationallyRanked #125
- 2024Entered Top 10% NationallyRanked #125
- 2024Entered Top 5% NationallyRanked #125
- 2024Entered Top 1% NationallyRanked #125
- 2025$25M Cumulative Funding
- 2026$50M Cumulative Funding